Catheter Precision Inc. (NYSE American: VTAK) has acquired a 19.98% equity stake in Fly Flyte, Inc., an FAA-certified regional aviation operator using AI-enabled operations and a fleet of Cirrus Vision Jets. The transaction provides VTAK immediate exposure to Flyte's revenue-generating, asset-backed business, with the potential for scalable fleet expansion and long-term equity upside. Flyte will maintain operating continuity and strategic control, while VTAK gains optionality for increased ownership or future monetization.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9655627-en) on February 17, 2026, and is solely responsible for the information contained therein.